This page includes Regulatory news filings supplied by issuers listed on the BSX. Please note the BSX is not responsible for the content, accuracy or completeness of announcements filed by issuers and disclaims all liability for any loss arising from reliance on information contained within issuer announcements.
Jazz Pharmaceuticals – Third Quarter 2023 Financial Results
Hamilton, Bermuda: 9 November 2023 – In a filing with the Bermuda Stock Exchange, Jazz Pharmaceuticals announces Third Quarter 2023 Financial Results. Click the link to view the full filing:
# # # #
About BSX
The Bermuda Stock Exchange (BSX) is a fully electronic, vertically integrated international securities market headquartered in Bermuda and organised in 1971. BSX specialises in the listing and trading of capital market instruments such as equities, debt issues, funds, hedge funds, derivative warrants, and insurance linked securities. To learn more about BSX visit https://www.bsx.com or contact info@bsx.com